![Hoe eenvoudige semantiek onze AI-citaties met 642% verhoogde [Nieuwe resultaten]](https://www.pharmamarketeer.nl/wp-content/uploads/2026/01/719-370x300.jpg)
Merck, a leading science and technology company, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion to update
Bayer’s Vitrakvi receives first tumor-agnostic approval in EU
Bayer announced that the European Commission has granted marketing authorization in the European Union (EU) for the precision oncology treatment Vitrakvi (larotrectinib). The drug is indicated for the treatment
EMA committee recommends marketing approval for Celltrion’s novel subcutaneous formulation of CT─P13 for RA treatment
Celltrion Healthcare, a global biopharmaceutical company, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion
MarketingTroonrede 2019: meer impact als marketeer
Wie droomt er nu niet van meer impact maken? We willen iedere dag nieuwe campagnes of merkverhalen laten landen, maatschappelijke ambities groots en meeslepend uitdragen, employer branding zich zien uitbetalen in de...
OrthoSpin receives US FDA approval for smart, robotic external fixation system for orthopaedic treatments
OrthoSpin Ltd, a portfolio company of The Trendlines Group Ltd. (Trendlines), announced that it received regulatory clearance from the United States Food and Drug Administration (FDA) for its smart, robotic
GSK’s oral nicotine spray wins divided FDA panel’s backing despite abuse risks
With the federal spotlight on e-cigarette use, the FDA has grown increasingly wary of nicotine-based products with risks of abuse. That didn’t stop GlaxoSmithKline from winning a recommendation for its over-the-counter...
Roche’s cobas Babesia receives US FDA approval
Roche announced that it has received approval from the US Food and Drug Administration (FDA) for the cobas Babesia test for use on the cobas 6800/8800 Systems for individual blood donation testing. This is
FDA approves Novo’s new type 2 diabetes pill
A new drug from Danish drug maker Novo Nordisk, called Rybelsus (semaglutide), has been approved by the FDA for the use in patients with type 2 diabetes to lower blood sugar levels. Rybelsus is the first drug in its...
Sanofi’s Troujeo beats insulin degludec in head-to-head study in type 2 diabetes
Sanofi took the opportunity at the 55th annual European Association for the Study of Diabetes to present new data from the first randomised control study directly comparing its Toujeo product with insulin degludec...
Novartis phase III PREVENT study of Cosentyx to treat patients with axial spondyloarthritis meets 16-week primary endpoint
Novartis, a leader reimagining rheumatology and immuno?dermatology, announced positive new data from the PREVENT trial evaluating the efficacy and safety of Cosentyx (secukinumab) in patients with nr-axSpA
Schrijf je 2020 Marketingplan op de Kondo-manier en vermijd CMO FOMO
Het is weer die tijd van het jaar waarin sommige CMO’s zich realiseren dat het marketingplan dat ze aan het begin van het jaar hebben opgesteld, toch iets anders is uitgepakt. Laat je daarom inspireren door de...
Roche wins FDA breakthrough for Gazyva in lupus nephritis
Drug originally approved as a lymphoma treatment
Abbott’s life-saving paediatric heart devices, Masters HP 15mm & Amplatzer Piccolo Occluder gets European approval
Abbott, a global healthcare leader, announced approvals in Europe for two of its life─saving paediatric devices. The Masters HP 15mm rotatable mechanical heart valve and the Amplatzer Piccolo Occluder have received
Roche’s Gazyva to treat lupus nephritis receives US FDA breakthrough therapy designation
Roche, a global pioneer in pharmaceuticals and diagnostics company, announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to Gazyva (obinutuzumab) for
FDA expands Janssen’s Erleada label to cover metastatic castration-sensitive prostate cancer
Janssen has announced that the FDA has expanded the label of its androgen receptor inhibitor Erleada (apalutamide) to include the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC). The...
7 pijnlijke lessen voor de marketingmanager van nu
Wat is jouw ambitie als marketeer? Wil je op een dag marketingmanager worden? Misschien wil je je eigen team, zelf je prioriteiten kiezen en eindverantwoordelijkheid dragen. Om hierin uit te blinken, moet je soms eerst...
The Most Important Lesson Learned at Content Marketing World
The motivation for Content Marketing World’s headliner keynotes – Henry Rollins and Mindy Kaling – are vastly different. But these two high-profile, highly successful creatives possess the same essential ingredient for...
Jasper Fraikin: ‘Contentmarketing draait teveel om de korte termijn’
In #34 van de Content Rally: Jasper Fraikin, medeoprichter van videoproductiebureau FJ. Hoe is zijn kijk op het contentmarketingvak?
